{"title":"撤回：LncRNA SNHG14通过miR-206/G6PD通路参与NSCLC的进展。","authors":"","doi":"10.1111/1759-7714.70154","DOIUrl":null,"url":null,"abstract":"<p><strong>Retraction: </strong>L. Zhao, X. Zhang, Y. Shi, and T. Teng, \"LncRNA SNHG14 Contributes to the Progression of NSCLC Through miR-206/G6PD Pathway,\" Thoracic Cancer 11, no. 5 (2020): 1202-1210, https://doi.org/10.1111/1759-7714.13374. The above article, published online on 09 March 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Tateaki Naito; and John Wiley & Sons Australia, Ltd. The retraction has been agreed upon following concerns raised by a third party regarding the use of an incorrect primer for the SNHG14 gene. The authors were invited to provide comments and supporting data but did not respond. Given the nature of the concern, the editors consider the results and conclusions of this article invalid. The authors did not respond to our notice of retraction.</p>","PeriodicalId":23338,"journal":{"name":"Thoracic Cancer","volume":"16 16","pages":"e70154"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378563/pdf/","citationCount":"0","resultStr":"{\"title\":\"RETRACTION: LncRNA SNHG14 Contributes to the Progression of NSCLC Through miR-206/G6PD Pathway.\",\"authors\":\"\",\"doi\":\"10.1111/1759-7714.70154\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Retraction: </strong>L. Zhao, X. Zhang, Y. Shi, and T. Teng, \\\"LncRNA SNHG14 Contributes to the Progression of NSCLC Through miR-206/G6PD Pathway,\\\" Thoracic Cancer 11, no. 5 (2020): 1202-1210, https://doi.org/10.1111/1759-7714.13374. The above article, published online on 09 March 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Tateaki Naito; and John Wiley & Sons Australia, Ltd. The retraction has been agreed upon following concerns raised by a third party regarding the use of an incorrect primer for the SNHG14 gene. The authors were invited to provide comments and supporting data but did not respond. Given the nature of the concern, the editors consider the results and conclusions of this article invalid. The authors did not respond to our notice of retraction.</p>\",\"PeriodicalId\":23338,\"journal\":{\"name\":\"Thoracic Cancer\",\"volume\":\"16 16\",\"pages\":\"e70154\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378563/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thoracic Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/1759-7714.70154\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thoracic Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1759-7714.70154","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
引用本文：赵莉，张晓霞，石毅，滕涛，“LncRNA SNHG14通过miR-206/G6PD通路参与NSCLC的进展”，《中华肿瘤杂志》，第11期。5 (2020): 1202-1210, https://doi.org/10.1111/1759-7714.13374。上述文章于2020年3月9日在线发表在Wiley在线图书馆（wileyonlinelibrary.com）上，经期刊主编内藤敦明（Tateaki Naito）同意撤回；及John Wiley & Sons Australia有限公司由于第三方对使用错误的SNHG14基因引物提出了担忧，因此同意撤回。作者被邀请提供评论和支持数据，但没有回应。鉴于关注的性质，编辑认为本文的结果和结论无效。作者没有回应我们的撤稿通知。
RETRACTION: LncRNA SNHG14 Contributes to the Progression of NSCLC Through miR-206/G6PD Pathway.
Retraction: L. Zhao, X. Zhang, Y. Shi, and T. Teng, "LncRNA SNHG14 Contributes to the Progression of NSCLC Through miR-206/G6PD Pathway," Thoracic Cancer 11, no. 5 (2020): 1202-1210, https://doi.org/10.1111/1759-7714.13374. The above article, published online on 09 March 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Tateaki Naito; and John Wiley & Sons Australia, Ltd. The retraction has been agreed upon following concerns raised by a third party regarding the use of an incorrect primer for the SNHG14 gene. The authors were invited to provide comments and supporting data but did not respond. Given the nature of the concern, the editors consider the results and conclusions of this article invalid. The authors did not respond to our notice of retraction.
期刊介绍：
Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.
The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
